Detalhe da pesquisa
1.
ADA2 deficiency complicated by EBV-driven lymphoproliferative disease.
Clin Immunol
; 215: 108443, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32353633
2.
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 9(4): 333-345, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38340759
3.
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Blood Cancer J
; 14(1): 66, 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38622139
4.
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma.
Blood Adv
; 7(12): 2872-2883, 2023 06 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36724512
5.
Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience.
J Med Microbiol
; 71(7)2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35819894
6.
Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis.
Leuk Lymphoma
; 63(8): 1980-1984, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35481791
7.
Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma.
Leuk Lymphoma
; 62(4): 1010-1012, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33275056